Prelude Therapeutics
PRLD
#8532
Rank
โ‚น23.96 B
Marketcap
โ‚น299.29
Share price
-0.77%
Change (1 day)
100.04%
Change (1 year)

Earnings for Prelude Therapeutics (PRLD)

Earnings in 2026 (TTM): -โ‚น6.17 Billion

According to Prelude Therapeutics's latest financial reports the company's current earnings are โ‚น22.42 Million. In 2025 the company made an earning of -โ‚น9.69 Billion, an increase over its 2024 earnings that were of -โ‚น12.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prelude Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น6.17 Billion-36.39%
2025 -โ‚น9.69 Billion-25.16%
2024 -โ‚น12.95 Billion5.62%
2023 -โ‚น12.26 Billion7.07%
2022 -โ‚น11.45 Billion8.62%
2021 -โ‚น10.54 Billion93.55%
2020 -โ‚น5.45 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion 131.67%๐Ÿ‡บ๐Ÿ‡ธ USA